PAMG
GSK icon

Patton Albertson Miller Group’s GSK GSK Stock Holding History

Patton Albertson Miller Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,974
Closed -$488K – 218
2022
Q2 		$488K Sell
8,974
-1,300
-13% -$71.8K 0.1% 162
2022
Q1 		$559K Buy
10,274
+120
+1% +$6.52K 0.1% 166
2021
Q4 		$560K Buy
10,154
+436
+4% +$22.7K 0.09% 175
2021
Q3 		$464K Buy
9,718
+460
+5% +$23.1K 0.09% 175
2021
Q2 		$461K Sell
9,258
-1,420
-13% -$68.2K 0.11% 147
2021
Q1 		$476K Sell
10,678
-35
-0.3% -$1.59K 0.12% 148
2020
Q4 		$477K Sell
10,713
-2,973
-22% -$137K 0.11% 148
2020
Q3 		$644K Sell
13,686
-1,636
-11% -$82K 0.18% 120
2020
Q2 		$781K Sell
15,322
-61
-0.4% -$3.13K 0.23% 114
2020
Q1 		$729K Sell
15,383
-149
-1% -$7.95K 0.25% 111
2019
Q4 		$912K Buy
15,532
+154
+1% +$8.57K 0.24% 114
2019
Q3 		$820K Sell
15,378
-819
-5% -$42.1K 0.23% 123
2019
Q2 		$819K Buy
+16,197
New +$813K 0.24% 120
2018
Q4 		– Sell
-660
Closed -$32K – 181
2018
Q3 		$32K Buy
+660
New +$33.5K 0.02% 197

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Patton Albertson Miller Group's GSK Position: Q3 2022 in Review

Patton Albertson Miller Group sold out of GSK (GSK) in Q3 2022, closing a stake of 8,974 shares — an estimated $488K sold.

Patton Albertson Miller Group first reported a position in GSK in Q3 2018 and held it in 14 quarters. The position peaked at $912K in Q4 2019. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Patton Albertson Miller Group reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Patton Albertson Miller Group sold 8,974 GSK shares in Q3 2022, an estimated $488K.
  • Patton Albertson Miller Group first reported a position in GSK in Q3 2018 and held it in 14 quarters.
  • Patton Albertson Miller Group's GSK position peaked at $912K in Q4 2019.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Patton Albertson Miller Group's 13F filing for Q3 2022, filed 13 Oct 2022.